Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials.

Silverberg JI, Wollenberg A, Reich A, Thaçi D, Legat FJ, Papp KA, Stein Gold L, Bouaziz JD, Pink AE, Carrascosa JM, Rewerska B, Szepietowski JC, Krasowska D, Havlíčková B, Kalowska M, Magnolo N, Pauser S, Nami N, Sauder MB, Jain V, Padlewska K, Cheong SY, Fleuranceau Morel P, Ulianov L, Piketty C, ARCADIA 1 and ARCADIA 2 Study Investigators

Open source

DOI: 10.1016/s0140-6736(24)01203-0
Published: 2024 Aug 3
Container: Lancet (London, England)
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-24-01203-0,
  title = {Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials.},
  author = {Silverberg JI and Wollenberg A and Reich A and Thaçi D and Legat FJ and Papp KA and Stein Gold L and Bouaziz JD and Pink AE and Carrascosa JM and Rewerska B and Szepietowski JC and Krasowska D and Havlíčková B and Kalowska M and Magnolo N and Pauser S and Nami N and Sauder MB and Jain V and Padlewska K and Cheong SY and Fleuranceau Morel P and Ulianov L and Piketty C and ARCADIA 1 and ARCADIA 2 Study Investigators},
  year = {2024},
  journal = {Lancet (London, England)},
  doi = {10.1016/s0140-6736(24)01203-0},
  url = {https://doi.org/10.1016/s0140-6736(24)01203-0}
}

RIS

TY  - JOUR
TI  - Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials.
AU  - Silverberg JI
AU  - Wollenberg A
AU  - Reich A
AU  - Thaçi D
AU  - Legat FJ
AU  - Papp KA
AU  - Stein Gold L
AU  - Bouaziz JD
AU  - Pink AE
AU  - Carrascosa JM
AU  - Rewerska B
AU  - Szepietowski JC
AU  - Krasowska D
AU  - Havlíčková B
AU  - Kalowska M
AU  - Magnolo N
AU  - Pauser S
AU  - Nami N
AU  - Sauder MB
AU  - Jain V
AU  - Padlewska K
AU  - Cheong SY
AU  - Fleuranceau Morel P
AU  - Ulianov L
AU  - Piketty C
AU  - ARCADIA 1 and ARCADIA 2 Study Investigators
PY  - 2024
JO  - Lancet (London, England)
DO  - 10.1016/s0140-6736(24)01203-0
UR  - https://doi.org/10.1016/s0140-6736(24)01203-0
ER  -

APA

JI, S., A, W., A, R., D, T., FJ, L., KA, P., L, S. G., JD, B., AE, P., JM, C., B, R., JC, S., D, K., B, H., M, K., N, M., S, P., N, N., MB, S., V, J., K, P., SY, C., P, F. M., L, U., C, P., & Investigators, A. 1. A. A. 2. S. (2024). Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(24)01203-0

Source records

pubmed · retrieved 2026-09-26T12:31:59.892Z
europe-pmc · retrieved 2026-09-26T12:31:59.885Z